---
document_datetime: 2023-09-21 19:30:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lusduna-epar-all-authorised-presentations_en.pdf
document_name: lusduna-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8668422
conversion_datetime: 2025-12-21 23:44:33.144238
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength     | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                            | Content (concentration)   | Pack size                              |
|------------------|-------------------|--------------|------------------------|---------------------------|------------------------------------------------|---------------------------|----------------------------------------|
| EU/1/16/1162/001 | LUSDUNA           | 100 units/mL | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen (Nexvue) | 3 mL                      | 1 pre-filled pen                       |
| EU/1/16/1162/002 | LUSDUNA           | 100 units/mL | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen (Nexvue) | 3 mL                      | 5 pre-filled pens                      |
| EU/1/16/1162/003 | LUSDUNA           | 100 units/mL | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen (Nexvue) | 3 mL                      | 10 (2 x 5) pre-filled pens (multipack) |

Medicinal product no longer authorised